News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Fiona BARRY
- Last updated on
Takeda Pharmaceutical Company Limited has promoted its Chief Operating Officer (COO) – and ex-GSK exec – to CEO.
Christophe Weber will continue in his additional roles as Representative Director and President of the company.
Yasuchika Hasegawa will step down as CEO but will remain a Representative Director and Chairman of the Board. The role of COO will be scrapped.
French national Weber, 49 years old, is the first foreign Chief for Takeda. Before joining the company in 2014, he was CEO of GSK France, followed by heading up GSK’s Vaccines and Biologicals units.
Yasuchika Hasegawa commented, “Since he became COO of the Company last April, I have been supporting Christophe and at the same time carefully observing his performance as a CEO successor. I have concluded that he is ready to assume Takeda’s CEO role, and therefore I have decided to appoint him CEO when the new organizational structure takes effect on April 1, 2015.”